Compare · head to head
Cohance Lifesciences vs Dottikon
Cohance Lifesciences ranks higher overall — 360 rank 37 vs 34.
Cohance Lifesciences leads on Quality (51 vs 36) and Safety (74 vs 61). Dottikon leads on Growth (60 vs 54) and Sentiment (49 vs 34). The two are close on Value.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Cyprus | Switzerland |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Small | Medium |
| ISIN | INE03QK01018 | CH0582581713 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 37 | 34 |
| Value | 24 | 28 |
| Quality | 51 | 36 |
| Growth | 54 | 60 |
| Safety | 74 | 61 |
| Sentiment | 34 | 49 |
| Quality details | ||
| Profitability | 47 | 38 |
| Cash Truth | 54 | 33 |
Cohance Lifesciences vs EuroapiCohance Lifesciences vs Teva Pharmaceutical IndustriesCohance Lifesciences vs MediwoundCohance Lifesciences vs Laboratorios Farmaceuticos RoviAdd a third stock →
Full analyses: Cohance Lifesciences · Dottikon
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100